High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer

Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy

Stéphanie Peeters, Wilma D. Heemsbergen, P. Koper et al. · Journal of Clinical Oncology · 2006 · 971 citations · Full text

Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09

Anthony L. Zietman, Kyounghwa Bae, Jerry D. Slater et al. · Journal of Clinical Oncology · 2010 · 737 citations

Trial Comparing, Radiation Medicine, Oncology +16

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

David P. Dearnaley, Gordana Jovic, Isabel Syndikus et al. · The Lancet Oncology · 2014 · 453 citations · Full text

A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy

Zachary S. Zumsteg, Daniel E. Spratt, Zhigang Zhang et al. · European Urology · 2013 · 396 citations

Therapeutic Decision, Decision Aid, Risk Management +13

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

Nikolaos Zamboglou, Nikolaos Tselis, Dimos Baltas et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 158 citations

Urology, Radiation Therapy, Medicine +6